Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 2/20 | 0.36 |
| ▸ | MAOB | P27338 | 5/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.35 |
| ▸ | HPGDS | O60760 | 2/20 | 0.34 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.34 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | SLC26A4 | O43511 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30656180 | 0.90 | HPGDS (0.37) | SCN9AMAOBEDNRAHPGDSGPR132 | |
| SCHEMBL30656124 | 0.90 | HPGDS (0.37) | SCN9AMAOBEDNRAHPGDSGPR132 | |
| SCHEMBL26792926 | 0.90 | SCN9A (0.33) | SCN9AEDNRAHPGDSSLC26A4 | |
| SCHEMBL30656325 | 0.90 | SCN9A (0.33) | SCN9AEDNRAHPGDSSLC26A4 | |
| SCHEMBL30656198 | 0.90 | SCN9A (0.33) | SCN9AEDNRAHPGDSSLC26A4 | |
| SCHEMBL30656258 | 0.88 | CD38 (0.37) | SCN9AMAOBEDNRAHPGDSGPR132 | |
| SCHEMBL30656226 | 0.88 | CD38 (0.37) | SCN9AMAOBEDNRAHPGDSGPR132 | |
| SCHEMBL31350322 | 0.86 | EDNRA (0.38) | MAOBEDNRASLC26A4 | |
| SCHEMBL30656142 | 0.85 | PARP10 (0.43) | MAOBEDNRAGPR132MAOA | |
| SCHEMBL30656003 | 0.85 | SCN9A (0.52) | SCN9AMAOBSCN3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4532013-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | Katholieke Universiteit Leuven KU Leuven Research & Development (BE) | 2025-04-09 | — | — | EP | claimed |
| WO-2023227697-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-11-30 | — | — | WO | claimed |
| EP-4532013-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | Katholieke Universiteit Leuven KU Leuven Research & Development (BE) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023227697-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-11-30 | — | — | WO | disclosed |